.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
McKinsey
Farmers Insurance
Fish and Richardson
Teva
Accenture
Harvard Business School
Baxter
Chinese Patent Office

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Sweden Patent: 9803239

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sentynl Theraps IncABSTRALfentanyl citrateTABLET;SUBLINGUAL022510-001Jan 7, 2011RXYesNo► Subscribe► SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Sentynl Theraps IncABSTRALfentanyl citrateTABLET;SUBLINGUAL022510-002Jan 7, 2011RXYesNo► Subscribe► SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Sentynl Theraps IncABSTRALfentanyl citrateTABLET;SUBLINGUAL022510-003Jan 7, 2011RXYesNo► Subscribe► SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Sentynl Theraps IncABSTRALfentanyl citrateTABLET;SUBLINGUAL022510-004Jan 7, 2011RXYesYes► Subscribe► SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Sentynl Theraps IncABSTRALfentanyl citrateTABLET;SUBLINGUAL022510-005Jan 7, 2011RXYesNo► Subscribe► SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
Sentynl Theraps IncABSTRALfentanyl citrateTABLET;SUBLINGUAL022510-006Jan 7, 2011RXYesNo► Subscribe► SubscribeYMANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist